Pathway analysis based on a genome-wide study of patients with both T1D and AIT implies that the signal transduction of cytotoxic T-lymphocyte antigen-4 (CTLA-4) and CD40 may be the principal pathway in their synergistic pathogenesis (45). This evidence concerns the gene CTLA4 and type 1 diabetes mellitus.